Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Long-term outcome of monoclonal (type 1) cryoglobulinemia.

Néel A, Perrin F, Decaux O, Dejoie T, Tessoulin B, Halliez M, Mahé B, Lamy T, Fakhouri F, Jego P, Agard C, Vigneau C, Guenet L, Grosbois B, Moreau P, Hamidou M.

Am J Hematol. 2014 Feb;89(2):156-61. doi: 10.1002/ajh.23608.

PMID:
24532335
[PubMed - indexed for MEDLINE]
2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
[PubMed - indexed for MEDLINE]
3.

Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.

Trejo O, Ramos-Casals M, López-Guillermo A, García-Carrasco M, Yagüe J, Cervera R, Font J, Ingelmo M.

Semin Arthritis Rheum. 2003 Aug;33(1):19-28.

PMID:
12920693
[PubMed - indexed for MEDLINE]
4.

Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature.

Payet J, Livartowski J, Kavian N, Chandesris O, Dupin N, Wallet N, Karras A, Salliot C, Suarez F, Avet-Loiseau H, Alyanakian MA, Nawakil CA, Park S, Tamburini J, Roux C, Bouscary D, Sparsa L.

Leuk Lymphoma. 2013 Apr;54(4):767-77. doi: 10.3109/10428194.2012.671481. Epub 2012 Apr 19. Review.

PMID:
22385269
[PubMed - indexed for MEDLINE]
5.

Clinical characteristics and outcome of immunoglobulin M-related disorders.

Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E.

Clin Lymphoma. 2005 Mar;5(4):261-4.

PMID:
15794861
[PubMed - indexed for MEDLINE]
6.

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.

Vidal L, Gafter-Gvili A, Gurion R, Raanani P, Dreyling M, Shpilberg O.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009045. doi: 10.1002/14651858.CD009045.pub2. Review.

PMID:
22972131
[PubMed - indexed for MEDLINE]
7.

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H.

Blood. 1998 Aug 15;92(4):1165-71.

PMID:
9694704
[PubMed - indexed for MEDLINE]
Free Article
8.

[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].

Vasil'ev VI, Probatova NA, Varlamova EIu, Tupitsin NN, Simonova MV, Safonova TN, Bozh'eva LA, Shornikova NS, Logvinenko OA, Belenin GIu.

Ter Arkh. 2004;76(8):61-8. Russian.

PMID:
15471400
[PubMed - indexed for MEDLINE]
9.

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

Terrier B, Karras A, Kahn JE, Le Guenno G, Marie I, Benarous L, Lacraz A, Diot E, Hermine O, de Saint-Martin L, Cathébras P, Leblond V, Modiano P, Léger JM, Mariette X, Senet P, Plaisier E, Saadoun D, Cacoub P.

Medicine (Baltimore). 2013 Mar;92(2):61-8. doi: 10.1097/MD.0b013e318288925c.

PMID:
23429354
[PubMed - indexed for MEDLINE]
10.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

PMID:
8611686
[PubMed - indexed for MEDLINE]
Free Article
11.

Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92).

Pillon M, Di Tullio MT, Garaventa A, Cesaro S, Putti MC, Favre C, Lippi A, Surico G, Di Cataldo A, D'Amore E, Zanesco L, Rosolen A.

Cancer. 2004 Jul 15;101(2):385-94.

PMID:
15241838
[PubMed - indexed for MEDLINE]
Free Article
12.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Terrier B, Launay D, Kaplanski G, Hot A, Larroche C, Cathébras P, Combe B, de Jaureguiberry JP, Meyer O, Schaeverbeke T, Somogyi A, Tricot L, Zénone T, Ravaud P, Gottenberg JE, Mariette X, Cacoub P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1787-95. doi: 10.1002/acr.20318.

PMID:
20740617
[PubMed - indexed for MEDLINE]
13.

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.

Treon SP, Branagan AR, Ioakimidis L, Soumerai JD, Patterson CJ, Turnbull B, Wasi P, Emmanouilides C, Frankel SR, Lister A, Morel P, Matous J, Gregory SA, Kimby E.

Blood. 2009 Apr 16;113(16):3673-8. doi: 10.1182/blood-2008-09-177329. Epub 2008 Nov 17.

PMID:
19015393
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Laszlo D, Andreola G, Rigacci L, Fabbri A, Rabascio C, Mancuso P, Pruneri G, Radice D, Pinto A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G.

J Clin Oncol. 2010 May 1;28(13):2233-8. doi: 10.1200/JCO.2009.23.6315. Epub 2010 Apr 5.

PMID:
20368573
[PubMed - indexed for MEDLINE]
15.

Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.

Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, Sala R, Cerretti R, Mandelli F.

Blood. 1999 Jul 15;94(2):448-54. Review.

PMID:
10397712
[PubMed - indexed for MEDLINE]
Free Article
16.

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.

Autoimmun Rev. 2011 Nov;11(1):48-55. doi: 10.1016/j.autrev.2011.07.005. Epub 2011 Jul 24. Review.

PMID:
21821153
[PubMed - indexed for MEDLINE]
17.

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ.

J Clin Oncol. 2008 Jan 10;26(2):196-203. doi: 10.1200/JCO.2007.11.8513.

PMID:
18182662
[PubMed - indexed for MEDLINE]
18.

[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].

Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):486-9. Chinese.

PMID:
16613686
[PubMed - indexed for MEDLINE]
19.

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA.

JAMA. 2007 May 9;297(18):2010-7.

PMID:
17488966
[PubMed - indexed for MEDLINE]
20.

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, Keating MJ.

J Clin Oncol. 2006 May 20;24(15):2343-51.

PMID:
16710033
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk